Pulmonary Langerhans Cell Histiocytosis in a young Non-Smoking Female --Too many Rituals spoil the Lung PLCH in a never smoker female

Main Article Content

Benhur Joel Shadrach
Diksha Agnihotri
Rishabh Goel
Hari haran

Keywords

PLCH, female, non-cigarette smoke.

Abstract

Pulmonary Langerhans cell histiocytosis (PLCH) is a rare idiopathic cystic interstitial granulomatous lung disease seen almost exclusively in cigarette smokers. It typically occurs between 20-40 years of age and equally distributed among both sexes. Management includes smoking cessation, avoidance of second-hand smoke, and close follow-up. Corticosteroids may be required in those with symptomatic disease with worsening lung function despite smoking cessation and progressive nodular stage of the disease. Here, we report an interesting case of biopsy-proven PLCH in a young never smoker female. Detailed questioning revealed significant exposure to incense smoke, highlighting a rare presentation of non-cigarette smoke-related PLCH. Avoidance of incense smoke combined with oral prednisolone (0.5mg/kg) tapered over 6 months led to complete resolution of symptoms, disappearance of nodules in high resolution computed tomography (HRCT) of the thorax and improvement in lung function.

Downloads

Download data is not yet available.
Abstract 142 | PDF Downloads 72

References

1. Lorillon G, Tazi A. How I manage pulmonary Langerhans cell histiocytosis. Eur Respir Rev. 2017;26:170070. doi:10.1183/16000617.0070-2017

2. Hidalgo A, Franquet T, Giménez A, et al. Smoking-related interstitial lung diseases: radiologic-pathologic correlation. Eur Radiol. 2006;16:2463–0. doi:10.1007/s00330-006-0340-0

3. Suri HS, Yi ES, Nowakowski GS, Vassallo R. Pulmonary langerhans cell histiocytosis. Orphanet J Rare Dis. 2012;7:16. doi:10.1186/1750-1172-7-16

4. Thomeer M, Demedts M, Vandeurzen K; VRGT Working Group on Interstitial Lung Diseases. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg. 2001;56:163–2. doi:10.1179/acb.2001.026

5. Vassallo R, Ryu JH, Schroeder DR, et al. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med. 2002;346:484–0. doi:10.1056/NEJMoa012087

6. Li Y, Zhen W, Costable U, et al. A confusing case report of pulmonary langerhans cell histiocytosis and literature review. Open Med (Wars). 2016;11:178–2. doi:10.1515/med-2016-0034

7. Tadokoro A, Ishii T, Bandoh S, Yokomise H, Haba R, Ishida T. Pulmonary Langerhans cell histiocytosis in a non-smoking Japanese woman. Nihon Kokyuki Gakkai Zasshi. 2011 Mar;49(3):203-7.

8. Fernandes L, Vadala R, Mesquita AM, Vaideeswar P. Rare interstitial lung disease: Pulmonary Langerhans Cell Histiocytosis in a young non smoking Indian female. Indian J Tuberc. 2015;62(1):46‐49. doi:10.1016/j.ijtb.2015.02.008

9. Deokar K, Niwas R, Chauhan N, et al. Recurrent pneumothorax, skin lesions and frequent urination. Breathe (Sheff). 2020;16(1):190318. doi:10.1183/20734735.0318-2019

10. Baqir M, Vassallo R, Maldonado F, et al. Utility of bronchoscopy in pulmonary Langerhans cell histiocytosis. J Bronchology Interv Pulmonol. 2013;20:309–2. doi:10.1097/LBR.0000000000000021

11. Roden AC, Yi ES. Pulmonary Langerhans Cell Histiocytosis: An Update From the Pathologists' Perspective. Arch Pathol Lab Med. 2016;140:230–40. doi:10.5858/arpa.2015-0246-RA

12. Canuet M, Kessler R, Jeung MY, Métivier AC, Chaouat A, Weitzenblum E. Correlation between high-resolution computed tomography findings and lung function in pulmonary Langerhans cell histiocytosis. Respiration. 2007;74(6):640‐646. doi:10.1159/000106843

13. Kinoshita Y, Watanabe K, Sakamoto A, Hidaka K. Pulmonary Langerhans Cell Histiocytosis-associated Pulmonary Hypertension Showing a Drastic Improvement Following Smoking Cessation. Intern Med. 2016;55:491–5. doi:10.2169/internalmedicine.55.5152

14. Tazi A, Soler P, Hance AJ. Adult pulmonary Langerhans' cell histiocytosis. Thorax. 2000;55:405–16. doi:10.1136/thorax.55.5.405

15. Vassallo R, Ryu JH, Colby TV, et al. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med. 2000;342:1969–78. doi:10.1056/NEJM200006293422607

16. Lorillon G, Bergeron A, Detourmignies L, et al. Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med. 2012;186:930–2. doi:10.1164/ajrccm.186.9.930

Most read articles by the same author(s)